Patients with deep venous thrombosis are at increased risk for developing post-thrombotic
syndrome as a result of deep venous obstruction and/or reflux leading to venous …

Endovascular venoplasty with iliofemoral venous stenting has become first-line therapy for
post-thrombotic iliofemoral venous obstructive lesions. As the risk of acute complications …

Deep vein thrombosis (DVT) is associated with a high cost burden for health care systems
because of secondary cost intensive complications like pulmonary embolism and especially …

Background As one of the primary etiologies of the post-thrombotic syndrome, chronic
venous occlusion is a huge burden on patient quality of life and medical costs. In this study …

Approximately 60% of patients with acute iliofemoral deep vein thrombosis recover without
further symptoms. However, 40% will have some degree of post-thrombotic syndrome (PTS) …

Venous obstructive lesions represent a therapeutic challenge. Postthrombotic lesions are
the most complex and very prone to rethrombosis. Technical success can be achieved in …

Traditional therapy of acute lower extremity deep venous thrombosis (DVT) has been
directed toward limiting progression of existing clot and preventing pulmonary emboli and …

Introduction Patients with deep vein thrombosis affecting the iliac and vena cava veins
develop a more severe post-thrombotic syndrome than those with femoropopliteal disease. It …

Chronic venous obstruction (CVO), including non-thrombotic Iliac Vein Lesions (NIVLs) and
post-thrombotic syndrome (PTS), presents a significant burden on patients' quality of life …

Iliofemoral deep venous thrombosis (DVT) poses a higher risk of ongoing problems than
more distal DVT. In selected patients, early treatment with thrombus removal as well as …